Key result
VEGFA supplementation increases heart organoid vascular network area ~2.4-fold, enabling functional sympathetic innervation.
This human iPSC-derived organoid system features coordinated cardiac, vascular, and neural development, providing a modular in vitro platform for studying heart morphogenesis and neurovascular interactions.
VEGFA enables functional neurocardiac coupling in organoids; extends in vitro platforms for heart-neural studies but leaves clinical translation open.
processes. Assembly of these vascularized EMOs with human iPSC-derived sympathetic neuron spheroids yields innervated EMOs exhibiting integrated neurovascular organization and functional responses to nicotine stimulation (iV-EMOs). This modular, developmentally guided organoid system features coordinated human cardiac, vascular, and neural development, providing a physiologically relevant platform for studying heart morphogenesis, neurovascular interactions, and regenerative therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Branco et al. (2026) studied Embryonic heart development. VEGFA and PDGFBB supplementation vs. Control organoids (no supplementation) was evaluated on Percentage of organoid area positive for endothelial cell marker CD31 (p=<0.0001). VEGFA supplementation significantly increased the CD31-positive vascular network area in heart organoids from 1.6% to 3.9%, which allowed for functional sympathetic innervation and physiologic response to nicotine when co-cultured with neuronal spheroids.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: